01 2Lexiscan
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 769
2020 Revenue in Millions : 542
Growth (%) : 100
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 719
2021 Revenue in Millions : 768
Growth (%) : -6
LOOKING FOR A SUPPLIER?